You are looking at 191 - 200 of 4,609 items for

  • Refine by Access: All x
Clear All
Full access

HSR24-129: Impact of Socioeconomic Status on Cancer Care in Southeast Texas: A Population-Based Cohort Study

Ahmed Abdelhakeem, Jacob Thompson, Junaid Anwar, Telice Terro, and Maryam Vasefi

Full access

HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System

Maria Lee, Jun Y. Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Oluyomi, Omar Rosales, Raka Bandyo, Courtney N. Miller-Chism, Mark M. Udden, Martha P. Mims, Hilary Ma, Gustavo A. Rivero, Akiva Diamond, Purnima S. Teegavarapu, Christopher R. Flowers, Ang Li, and Sara Taveras Alam

Full access

HSR24-131: Patient Experiences and Perceptions of Biomarker Testing in AML and CML: A Qualitative Analysis

Erica Fortune, Abigail Newell, Maria Gonazlo, Madyson Popalis, and Elif Andac-Jones

Full access

HSR24-132: Value of Early Transfusion Burden Reduction in Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Anna Coughlan, Sven L. Klijn, Hong Xiao, Benjamin White, Conrado Franco-Villalobos, Alina Sichevaya, Ahmed Hnoosh, Dimana Miteva, and Aylin Yucel

Full access

HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States

Kirollos S. Hanna, Rui Song, Samantha Slaff, Enrico Zanardo, Lynn Huynh, Manasi Mohan, Megan Pinaire, Derek Tang, Mihran Yenikomshian, Victoria Barghout, Adeola Y. Makinde, and Kashyap Patel

Full access

HSR24-134: Perceptions of CARTITUDE-4 for Patients With Relapsed/Refractory Multiple Myeloma

Brooke Dulka, Luke Jennings-Zhang, Samuel Baird, Robert N. Bone, Yolaine Jeune-Smith, Muhamed Baljević, and Bruce Feinberg

Full access

HSR24-135: Community Oncologists’ Perceptions on the Evolving Role of Surrogate Endpoints in Oncologic Clinical Trials

Brooke Leon, Robert N. Bone, Yolaine Jeune-Smith, and Bruce Feinberg

Full access

HSR24-136: The Impact of Prescription Drug Plan (Part D) Enrollment for Medicare Beneficiaries on Eligibility for Episodic Value-Based Care Model Participation and Total Cost of Care (TCOC) at a Community Oncology Network

Jennifer Fernandez, John Albaugh, Lora Markley, Puneeth Indurlal, and Lalan Wilfong

Full access

HSR24-137: Does Routine Clinical Assessment of Older Adults With Gastroesophageal Cancer Tell the Whole Story?

Lauren Laderman, Meghan Connors, Caitlin R. Meeker, Elizabeth A. Handorf, Kelly A. Filchner, Mohamedtaki A. Tejani, Grant R. Williams, Arthur Winer, Sukeshi P. Arora, Namrata Vijayvergia, and Efrat Dotan

Full access

HSR24-138: Real-World Treatment (tx) Patterns and Outcomes for First-Line (1L) Novel Hormonal Agent (NHA) Naïve Metastatic Castration Resistant Prostate Cancer (mCRPC) Including in Black and/or African American (BAA) Patients (Pts)

Emily Nash Smyth, Samuel Whipple, Mark Guinter, Nadine Haddad, Wenxian Piao, Zhanglin Cui, and Arjun Balar